RecruitingNCT06758271

Special Drug Use-results Survey for Long-term Use（Avacopan）

Special Drug Use-results Survey for Long-term Use

Sponsor

Kissei Pharmaceutical Co., Ltd.

Enrollment

250 participants

Start Date

Jul 29, 2022

Study Type

OBSERVATIONAL

Conditions

Microscopic Polyangiitis (MPA)Granulomatosis With Polyangiitis (GPA)

Summary

The purpose of this survey is evaluating the safety and efficacy of long-term administration of avacopan for Japanese patients with microscopic polyangiitis or granulomatosis with polyangiitis under actual conditions of use.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Avacopan for people with granulomatosis with polyangiitis (gpa) and microscopic polyangiitis (mpa). The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.